Small molecules against RNA targets attract big backers
Nature Reviews Drug Discovery 16, 813 (2017).
doi:10.1038/nrd.2017.239
Author: Asher Mullard
Novartis, Merck, Pfizer and biotech entrepreneurs have started working on small-molecule drugs that act on an assortment of RNA targets, hoping to unlock once undruggable targets and new biology.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Asher Mullard Tags: News and Analysis Source Type: research